Synergy stock


Analyst Cuts Price Target on Synergy Pharmaceuticals Inc (SGYP); All Chips Are Riding on Trulance Uptake

Though Cantor’s William Tanner keeps SGYP’s capital needs and prospective dilution in mind, he is confident on Trulance’s uptake in the market.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts